Biotech News
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
investors.twistbioscience.com2026-05-06 14:56 EST
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 12, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025 .